课题基金 / 基金详情

Pathogenesis of peritoneal dissemination

Pathogenesis of peritoneal dissemination
腹膜播散的发病机制
批准号:
07671838
负责人:
KATO Tomoyasu
金额:
$1.41万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1997

项目摘要

项目成果

KATO Tomoyasu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In order to clarify the mechanisms to explain of production of peritoneal dissemination, the following studies were perfomed.1. Post-operative peritoneal washing cytology in cases of endometrial carcinoma with positive peritoneal cytology. In order to assess the potential of malignant cells in the petitoneal cavity to metastasize, post-operative peritoneal cytology was undertaken. In 12 cases with endometrioid adenocarcinoma and intra-operative positive peritoneal cytology, a Silascon tube was indwelt in the abdominal cavity before closure of the abdomen. The peritoneal cavity was washed with saline 14 days after operation. The cytology of recovered washing was negative in all cases.2. Role of integrin on access of endometrial cancer cells into the pelvic cavity via the fallopian tube. I investigated the relationship between the expression of integrin and cases which had both superficial myometrial invasion and no lymph node metastasis and peritoneal positive cytologh. I showed that all four cases with histological grade 2 had the expression of beta3 integrin.3. Role of integrin on endometrial cancer metastasis to adnexa.I showed the significant relationshipm between the expression of beta1 integrin and adnexal metastasis (p<0.001).4. Risk of peritoneal dissemination in endmerial cancer or gastric cancer.I investigated the risk of peritoneal disseminataion in endometrial cancer and gastric cancer metastasis to ovary. I showed that the risk of peritoneal dissemination was lymph node metastasis rather than malignant cells in pelvic cavity.The above studies demonstrated that malignant cells in the peritoneal cavity appear to have a very low potential fora implantation into the peritoneum.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Kato, T., Hirai, T., Hasumi, K.: "Post-operative peritoneal washing cytology in cases of stage IIIa endometrial carcinoma with positive peritoneal cytology" Acta Obst.Gynaec.Jpn.47(7). 643-646 (1995)
Kato, T.、Hirai, T.、Hasumi, K.:“腹膜细胞学阳性 IIIa 期子宫内膜癌病例的术后腹膜冲洗细胞学检查”Acta Obst.Gynaec.Jpn.47(7)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kato, T., Hirai, Y., Hasumi, K.: "Clinical problem in stage IIIa of corpus sancer staging" Obst.Gynec.Therapy. 71(4). 462-465 (1995)
Kato, T.、Hirai, Y.、Hasumi, K.:“Corpus sancer 分期 IIIa 期的临床问题”Obst.Gynec.Therapy。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
加藤友康: "筋層浸潤の欠如した子宮体癌IIIa期の検討" JAPANESE JOURNAL OF CANCER RESEARCH. Vol87 Supplement. 569-569 (1996)
Tomoyasu Kato:“缺乏肌肉侵袭的 IIIa 期子宫内膜癌的研究”日本癌症研究杂志第 87 卷增刊(1996 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
加藤 友康 他: "術中腹腔細胞診陽性により子宮体癌IIIa期と分類することの問題点" 産婦人科治療. 71. 462-465 (1995)
Tomoyasu Kato 等人:“根据术中腹膜细胞学检查阳性将子宫内膜癌分类为 IIIa 期的问题。妇产科治疗”71. 462-465 (1995)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
10
    Establishment of the framework for republication and compilation of historical source materials concerning pre-modern Japan in the network environment.
    • 批准号:
      21240022
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $30.12万
    • 财政年份:
      2009
    • 负责人:
      KATO Tomoyasu
    • 依托单位:
    Using Visual Sources to Understand the Spatial and Temporal Transition in Premodern Japanese Ritual
    • 批准号:
      16202014
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $30.04万
    • 财政年份:
      2004
    • 负责人:
      KATO Tomoyasu
    • 依托单位:
    Research for the Multi-Media databases of the Japanese History and their On-Line Access on the WWW server.
    • 批准号:
      08408011
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $20.42万
    • 财政年份:
      1996
    • 负责人:
      KATO Tomoyasu
    • 依托单位:
    国内基金
    海外基金
    血管衰老通过lumican-integrinα2β1通路诱导NVU调控认知障碍的分子机制及干预靶点研究
    • 批准号:
      JCZRLH202602095
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    β1-integrin介导的Warburg效应在TAM耐药乳腺癌中的作用及机制
    • 批准号:
      JCZRLH202600554
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    睡眠剥夺经TNN/Integrin α8β1轴调控巨噬细胞极化促动脉粥样硬化的作用及机制研究
    • 批准号:
      2025JJ60778
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      高嘉慧
    • 依托单位:
    维生素D受体通过抑制Mucin-1/β1-integrin信号通路调节肠道衰老的相关机制研究